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ABSTRACT 
 
Non-invasive prenatal testing (NIPT) using cell free DNA for aneuploidy is a highly 
accurate screening test, however concerns exist around the potential for routinisation of 
testing. The multidimensional measure of informed choice (MMIC) is a quantitative 
instrument developed to assess informed choice for Down syndrome screening. We have 
validated a modified MMIC for NIPT and measured informed choice amongst women 
offered NIPT in a public health service. The measure was distributed to women recruited 
across eight maternity units in the United Kingdom who had accepted Down syndrome 
screening. Construct validity was assessed by simultaneously conducting qualitative 
interviews. 585 questionnaires were completed and 45 interviews conducted after blood-
draw (or equivalent for those that declined NIPT). The measure demonstrated good 
internal consistency and internal validity. Results indicate the vast majority of women 
(89%) made an informed choice; 95% were judged to have good knowledge, 88% had a 
positive attitude and 92% had deliberated. Of the 11% judged to have made an 
uninformed choice, 55% had not deliberated, 41% had insufficient knowledge, and 19% 
had a negative attitude. Ethnicity (OR=2.78, p=0.003) and accepting NIPT (OR=16.05, 
p=0.021) were found to be significant predictors of informed choice. The high rate of 
informed choice is likely to reflect the importance placed on the provision of pre-test 
counselling in this study. It will be vital to ensure this is maintained once NIPT is offered in 
routine clinical practice. 
 
Keywords: non-invasive prenatal testing, informed choice, Down syndrome, aneuploidy 
 
 
 
 
 
 
3 
 
INTRODUCTION 
In most developed countries it is now routine practice to offer pregnant women Down 
syndrome screening followed by invasive testing for definitive diagnosis for those women 
at increased risk.1 The limitations of this approach are that Down syndrome screening 
(DSS) currently has a detection rate (DR) of around 80-90% and a false positive rate 
(FPR) of 3-5%,2 and invasive testing through chromosome analysis of amniocytes or 
chorionic villus samples (CVS) carries a procedure-related miscarriage risk of 0.5-1%.3 
Following the identification of cell-free DNA (cfDNA) in the maternal plasma in the late 
1990’s4 together with the technological advances delivered by next generation sequencing, 
it has become possible to offer non-invasive prenatal testing (NIPT) for aneuploidy. It has 
been clinically available in the private sector since 2011, and is currently being evaluated 
for use within several publicly funded healthcare systems.5-7 It has high detection rates 
(DRs) and low false positive rates (FPRs) for Down syndrome (99.0%DR; 0.08%FPR) as 
well as trisomies 18 (92.1%DR; 0.20%FPR) and 13 (88.6%DT; 0.12FPR),8 but as NIPT 
requires confirmation through invasive testing it is considered to be an advanced 
screening test.9 The clinical advantages of NIPT are the reduced need for invasive testing, 
and the opportunity for earlier reassurance as NIPT can be conducted from 10 weeks 
gestation. Concerns around routinisation of testing because of the ease with which this 
near-diagnostic test can be conducted have also been raised.10,11 Consequently, much 
discussion has centred around the importance of non-directive counselling and ensuring 
informed choice when offering NIPT. 1,9,  As such, any evaluation of implementing NIPT 
into clinical practice should include an assessment of whether women are making informed 
choices. 
There is a consensus in clinical guidelines published in the UK, USA and elsewhere 
that prenatal testing services should facilitate women to make informed choices.12-14 
Whilst numerous definitions of informed choice exist,15-17 how to assess informed choice 
has been widely debated and several validated measures have been developed.17-19 One of 
the most accepted quantitative measures is the Multidimensional Measure of Informed 
Choice (MMIC)17,20, which is based on a definition of informed choice being one made with 
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sufficient knowledge, in line with the persons values and attitudes to testing, and 
behaviourally implemented. The MMIC was originally developed for women undergoing 
DSS,20 but has been adapted for other conditions including screening for thalassaemia and 
sickle cell21, fragile X syndrome22 and cancer.23 Our aim was to validate a modified MMIC 
instrument for NIPT and measure informed choice amongst women offered NIPT following 
DSS in a public health service.  
 
MATERIALS AND METHODS 
We describe the development of a modified MMIC as a measure of informed choice for 
women offered NIPT for aneuploidy following DSS. This work forms part of a larger study 
(The NIPT Evaluation Study) evaluating the implementation of NIPT within the National 
Health Service (NHS) (www.rapid.nhs.uk/).5 NHS Research Ethics Committee approval 
was obtained (London – Camden and Islington 13/LO/0082) in February 2013. 
 
1. Adaptation of MMIC 
The original MMIC comprised a knowledge scale, scored as good or poor knowledge, and 
an attitude scale, scored as positive or negative attitude, which was then combined with 
test behaviour to determine if an informed choice had been made.17 To refine the MMIC 
for use with NIPT a multidisciplinary expert panel was established to assist in this process. 
They comprised a specialist in fetal medicine and NIPT, a genetic counsellor with expertise 
in developing competences for health professionals, the Associate Director of the NHS 
Genetics and Genomics Education Centre, a research genetic counsellor, two research 
midwives and representatives from the patient organisations Antenatal Results and 
Choices and Genetic Alliance UK. 
 
Knowledge scale 
Adaption of the MMIC requires the development of a knowledge scale specifically for the 
condition and screening test being used. An initial set of 11 knowledge items for NIPT 
were generated by CL. These were informed by: previous qualitative interviews exploring 
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patient’s informational needs regarding NIPT11, a patient information leaflet developed by 
the expert panel for use in the Evaluation Study, clinical guidelines for offering NIPT1,24 
and questions used in the original MMIC knowledge scale.17 The knowledge items were 
designed to cover four domains: 1) characteristics of NIPT, 2) how NIPT compares with 
standard DSS, 3) implications of testing, and 4) knowledge about condition(s) for which 
testing is being offered. These were presented in a multiple choice format with a range of 
three to six potential choices. To refine the knowledge items, a series of consultations 
were conducted with the members of the expert panel. During the first round of 
consultation, the expert panel were asked to rate each knowledge item on a scale of 1 to 5 
(1 = not at all, 5 = extremely) in terms of both the importance and difficulty. The panel 
were also asked whether any important questions were missing. Following consultation, 
some questions were reworded and one additional question was included to address 
participants’ understanding of a ‘highly unlikely’ NIPT result.  
During the second round of consultation the panel were again asked to rate the 
importance and difficulty of each question. No further amendments to the questions were 
made. As there is no external criteria for what constitutes ‘good’ or ‘poor’ knowledge, the 
panel agreed a cut-off of ≥9/12 would constitute good knowledge. In addition, it was 
agreed that the responder had to answer the question about what condition(s) NIPT was 
testing for correctly as this was considered crucial to making an informed choice.   
 
Attitude scale 
The items for inclusion into the attitude scale were also subject to a round of consultation 
with the expert panel. It was agreed to include three of the four items used in the original 
MMIC scale17 (beneficial/harmful; important/unimportant; good thing/bad thing) which 
had been validated in the prenatal setting20. However, there was consensus that the 
fourth item (pleasant/unpleasant) did not represent an important aspect of women’s 
attitude towards NIPT because women have many blood tests during pregnancy. The 
panel agreed to include two other items, desirable/undesirable and reassuring/not 
reassuring, which had been validated in other modified MMIC scales.25,26 The expert panel 
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were asked to agree a cut-off for the attitude scale. The options included the midpoint of 
the scale (≥11, range 0-20) in line with the original application of the MMIC attitude 
scale20 or an alternative cut-off used by Van den Berg and colleagues27 in which attitude is 
scored into three equal categories (positive, neutral and negative) and people with a 
neutral attitude are removed from the informed choice calculation. The expert panel 
unanimously agreed on the Van den Berg approach.   
 
Deliberation scale 
Deliberation is considered to be a key component of the decision-making process in many 
health behaviour theories,28,29 and a deliberation scale has been included alongside the 
original MMIC in a previous study measuring informed choice in prenatal screening. 30 The 
panel agreed to include the deliberation scale in the questionnaire and the results of 
informed choice are presented both with and without this scale.  
 
Piloting the questionnaire 
In the final stage of development the MMIC was piloted with 20 women who had been 
offered NIPT as part of the NIPT Evaluation Study. A researcher (CL) then conducted a 
short face to face interview with each responder to assess the clarity of question and 
answer options. Some minor modifications to wording were made. The questionnaire 
including the final MMIC scale is included in the Supplementary Information.  
 
2. Study Procedure 
A protocol detailing recruitment into the Evaluation Study has been published.5 Briefly, 
women were recruited through one of eight antenatal clinics located across the UK which 
varied in terms of the demography of their catchment areas. Women were eligible to 
participate if they had accepted DSS as part of routine care, were older than 16 years, had 
a singleton pregnancy and able to read and understand English (due to resource 
constraints we were unable to translate the information materials and questionnaire) and 
provide informed consent. Those with an intermediate (1:1000-1:151) or high risk result 
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(1:150-1:2) following DSS were invited into the Evaluation Study and offered NIPT free of 
charge. Women with an intermediate risk DSS result were offered NIPT or no further 
testing; women with a high risk DSS result were offered NIPT, invasive testing, NIPT and 
invasive testing or no further testing. All women received individualised pre-test 
counselling with a dedicated NIPT research midwife as well as written information about 
NIPT at two time points (booking-in and pre-test counselling) prior to decision-making. 
Information given to women during pre-test counselling is summarised in Figure 1. A 
subset of women eligible for the Evaluation Study was invited to take part in the Informed 
Choice study. Women were recruited as a consecutive sample between December 2013 
and February 2015. This was a longitudinal cohort study involving questionnaires and 
interviews at two time points. Only questionnaire and interview responses from the first 
time-point (T1) are presented here as these relate directly to validation of the amended 
MMIC 
 
Questionnaires 
The first questionnaire (Q1) was given to women after blood had been taken (or within a 
similar timeframe for women who declined testing). Q1 contained the modified MMIC as 
well as: The Decisional Conflict Scale; 31 the short form of the State Trait Anxiety 
Inventory (STAI-6);32 questions to explore motivations for testing and preference for test 
attributes; questions on parity and socio-demographic questions (Table 1). The results 
from these additional questions are presented in a forthcoming paper (“Women’s 
experience of being offered non-invasive prenatal testing for aneuploidy in a national 
health service setting” manuscript in preparation). Participants were requested to leave 
their contact details so that a follow-up questionnaire could be sent and indicate their 
willingness to take part in an interview. We aimed to collect at least 50 completed 
questionnaires from women seen consecutively at each of eight participating maternity 
units. Based on the results of the informed choice study by Michie et al. 20 a sample of 350 
completed questionnaires would detect a difference of 10% in rates of informed choice 
with 97% power at the 5% level of significance.   
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Interviews 
Semi-structured interviews were conducted with a subset of women. The interviews 
included questions drawn from the concepts of the MMIC (knowledge, attitude and 
deliberation). Construct validity of the measure was assessed by comparing women’s 
scores on the questionnaire with their responses during interview. Interviews were also 
used to validate the cut-off for good knowledge. In asking women to recount what 
information they remembered being given about NIPT, the aim was not only to assess 
recall of information but also ensure understanding of the implications of the test. 
Women’s attitudes towards NIPT were assessed through exploring their reasons for 
accepting or declining testing, and the values underpinning those attitudes. Deliberation 
was assessed through exploring whether they had considered the possible consequences 
of NIPT or evaluated alternative options. Participants were purposively sampled to 
represent a range of demographic groups (educational level, ethnicity, religion and 
religiosity), testing choices, MMIC scores and test outcomes. Interviews were conducted 
until saturation was reached. 
  
3. Data Analysis 
Analysis of the MMIC 
To assess informed choice, knowledge scores (which were dichotomized as good or poor), 
attitude scores (which were classified as positive, negative or neutral with neutral 
responders being omitted) and deliberation scores (which were dichotomized as 
deliberated or non-deliberated) were combined with test behaviour. When participants had 
good knowledge, had deliberated, and if attitude was consistent with test uptake, an 
informed choice had been made. If knowledge was poor, the choice was not deliberated or 
if attitude was not consistent with test uptake, an uninformed choice had been made.  
Reliability of the knowledge, attitude and deliberation scales was assessed using 
Cronbach’s alpha which measures internal consistency. Alpha values of 0.7-0.9 are 
assumed to indicate good internal consistency.33 Construct validity of the adapted attitude 
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scale was also measured using factor analysis to determine whether the items spanned 
one or more dimensions.34 To validate the cut-off for good knowledge women’s mean 
knowledge scores were compared using the t-test. To look at the impact of socio-
demographic variables on informed choice, descriptive analysis was conducted on single 
items; relationships between groups were tested using chi-square tests and Fisher’s exact 
test for categorical variables and the Kruskal-Wallis test for continuous variables. Due to 
the dominance of one category in the variables education, ethnicity and religion, the 
categories were collapsed into binary categories to strengthen the analysis i.e. White 
ethnicity v other, degree education or higher v other, Christian v other. Logistic regression 
analysis was conducted to determine which independent variables were significant 
predictors of informed choice. Missing data on the knowledge scale were treated as 
incorrect answers. Questionnaires with missing data on the attitude and knowledge scale 
were removed from analysis as they prohibited calculation of informed choice. Data were 
analysed using SPSS 22 (IBM, Chicago, IL, USA).  
 
Analysis of qualitative interviews 
Construct validity of the MMIC was also assessed by comparing results of the component 
scales with qualitative responses from interviews. This validation process was undertaken 
by two researchers independently (CL and MH). Qualitative data were independently 
coded by CL and MH to score knowledge (good or poor), attitude (positive, negative or 
neutral) and deliberation (deliberated or non-deliberated). The results were compared 
following independent analysis and any discrepancies discussed until consensus was 
reached. For each participant the assessment of whether an informed choice had been 
made was then compared back to the assessment made via the MMIC.  
 
RESULTS 
Participant Characteristics 
In total, 731 women were invited to take part in the Informed Choice study and 593 
agreed to participate and completed Q1 (81% response rate). During the first phase of 
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data analysis, eight questionnaires were removed due to missing data (N=585). A 
summary of maternal characteristics are presented in Table 1. Regarding DSS risk, 72% of 
women had an intermediate risk and 28% were high risk. Regarding NIPT uptake, in the 
intermediate risk group (n=421), 97% chose NIPT and 3% chose no further testing. In the 
high risk group (n=163), 86% chose NIPT and 14% chose NIPT and invasive testing. We 
do not have demographic or testing decision data for participants who declined to 
participate in the Informed Choice study.   
 
Internal Reliability 
The alpha coefficients for the knowledge, attitude and deliberation scales indicated internal 
reliability (Table 2). The scree test for the factor analysis showed an elbow between 
factors 1 and 2. . The factor, with an eigenvalue of 4.12, accounted for 82% of the 
variability across the five items of the attitude scale, indicating construct validity.  
 
Construct validity 
Forty five interviews were conducted with women at T1 to assess and explore knowledge, 
attitude and deliberation. Forty three women were judged to have good knowledge (96%), 
41 were judged to have a positive attitude (91%) and 44 were judged to have deliberated 
(98%). Example quotes illustrating knowledge, attitude and deliberation are presented in 
Table 3. The interview assessment of informed choice was then compared to the 
corresponding questionnaire. Overall, five (11%) discrepancies were identified; in two 
cases these related to attitude, in two cases deliberation, and in one case a discrepancy 
was found for both deliberation and knowledge. In each case the participant had failed to 
reach the required cut-off on the questionnaire but had displayed adequate knowledge, a 
positive attitude and deliberation during the interview. The knowledge scores were 
significantly higher in women judged at interview to have good knowledge (M=11.12, 
SD=1.31) compared with those judged to have poor knowledge (M=6; SD=1.41), 
suggesting the cut-off for what constitutes good knowledge was appropriate (t(43)=5.38, 
p<0.001).   
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Informed choice 
According to the MMIC, 89% (n=467) of women were judged to have made an informed 
choice about NIPT. When we excluded the deliberation scale this increased slightly to 94% 
(n=492).  
Of the total sample, 95% (n=553) were judged to have good knowledge, 88% 
(n=513) had a positive attitude (2% had a negative attitude, and 10% had a neutral 
attitude and were excluded from the informed choice calculation) and 92% (n=539) had 
deliberated. In all cases apart from one, the informed choices made (when deliberation 
was included in the measure) were those in which women had good knowledge, a positive 
attitude, had deliberated on their decision and had undergone testing. In one case a 
woman had made an informed choice based on good knowledge, deliberation, a negative 
attitude and had declined invasive testing. Of the 11% (n=58) who were judged to have 
made an uninformed choice, 55% (n=32) had not deliberated, 41% (n=24) had 
insufficient knowledge, and 19% (n=11) had a negative attitude (eight of whom accepted 
NIPT and three of whom declined).  
Bivariate analysis showed that women found to have made an informed choice 
were significantly more likely to be: NIPT accepters (OR=5.38, p<0.001), White 
(X2(1)=12.99, OR=1.15, p<0.001), university educated (X2(1)=4.10, OR=1.07, p=0.043) 
and high risk (X2(1)=4.082, OR=1.07, p=0.043). There was no significant difference in 
rates of informed choice across antenatal clinics (p=0.101). Multivariable regression 
analysis demonstrated that ethnicity and NIPT uptake were significant predictors of 
informed choice when controlling for education, age, having a religious faith, parity and 
screening risk. White participants had almost three times higher odds of making an 
informed choice than other ethnic groups who were more likely to agree to testing despite 
their beliefs (OR=2.78, 95%CI: 1.42 to 5.46, p=0.003); NIPT accepters had 16 times 
higher odds of making an informed choice than NIPT decliners (OR=16.05, 95%CI: 1.53 
to 168.81, p=0.021) although the large confidence interval indicates a low level of 
precision due to the small number of NIPT decliners in the study (Table 4).  
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Knowledge, attitude and deliberation scores 
A Kruskal-Wallis test revealed significant differences in knowledge and attitude scores and 
a number of socio-demographic variables. Knowledge scores were significantly affected by 
education (H(4)=41.99, p<0.001) and ethnicity (H(4)=20.21, p=<0.001). Pairwise 
comparisons with a Bonferroni correction for multiple comparisons revealed participants 
with no qualification (U=191.08, p=0.027, r=-.16), GCSE/O level qualifications 
(U=119.03, p<0.001, r=-.15) and vocational qualifications (U=63.86, p=0.001, r=-.18) 
had significantly lower knowledge scores compared to those with a university degree; and 
Asian participants had significantly lower knowledge scores compared to White participants 
(U=65.64, p=0.012, r=-.15). Attitude scores were also significantly affected by education 
(H(4)=9.99, p=0.041) and ethnicity (H(4)=24.43, p<0.001). Pairwise comparisons 
revealed participants with vocational qualifications had significantly more negative 
attitudes towards NIPT compared to those with a university degree (U=46.55, p=0.034, 
r=-.14); and Black participants had significantly more negative attitudes compared to 
White participants (U=112.39, p<0.001, r=-.21). Screening risk was also found to be 
significantly associated with attitude and deliberation scores; women with a high risk DSS 
result had more positive attitudes towards NIPT than those with a low risk result 
(U=30846, z=-2.15, p=0.032,r=-.09) and had deliberated more (U=26504, z=-4.33, 
p<0.001, r-.18).  
 
DISCUSSION 
This is, to our knowledge, the first adaptation of the MMIC scale for use with women 
considering NIPT for aneuploidy. The vast majority of participants in this sample were 
found to have made an informed choice, although we recognise that these results 
represent a specific research project and is likely to reflect the high importance placed on 
the provision of pre-test counselling to facilitate informed choice. These findings do 
however emphasise the importance of providing pre-test counselling in future NIPT 
programmes including providing patients with sufficient information and support.. This 
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finding is in stark contrast to previous research on informed choice in DSS35 which has 
generally found rates of informed choice to be low,17,26,36,37 commonly due to poor 
knowledge.19,36,37 Introducing NIPT for aneuploidy outside of a research setting is likely to 
result in less time for pre-test counselling specifically around this test which has the 
potential to impact on patient knowledge and consequently informed choice. This concern 
is supported by recent research in the USA with genetic counsellors offering NIPT for 
aneuploidy, which suggests that a large number of patients do not understand that NIPT is 
a screening test.38 If and when the test is adopted into standard maternity care pathways, 
evaluation will be needed to confirm whether women are making informed choices. 
In this study, non-White participants and participants with a lower educational level 
were significantly less likely to make an informed choice. This is in line with previous 
research assessing informed choice amongst women offered prenatal screening in the UK, 
where South Asian and Black African Caribbean women and those from low socioeconomic 
backgrounds were less likely to make an informed choice than other women.39 Similarly, in 
a study conducted in the Netherlands, women of Turkish and Surinamese origin were less 
likely to make an informed choice than those of Dutch origin.40 These observations support 
the theory that healthcare systems are less good at facilitating informed choice in the 
prenatal setting for women from minority ethnic groups and from lower educational 
backgrounds. This may be for a number of reasons including inequity of access for ethnic 
minority groups,41 or that pre-test counselling and/or informed choice measures are too 
complex for those with low literacy levels.42 Our findings suggest that poor knowledge and 
negative attitudes played a significant role. This emphasizes the importance of finding 
ways to enhance the informed choice process amongst different cultural and economic 
groups in order not to exacerbate the health divide, for example through different media 
formats to enhance understanding or decision aids to help clarify women’s attitudes. 
Further research in this area would therefore be valuable.   
Interestingly, the greatest number of uninformed choices were made as a result of 
decisions not being deliberated on. This may be because reporting whether one has 
deliberated on something is more difficult than reporting on one’s knowledge or attitudes, 
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or because women did not necessarily deliberate on the decision to have NIPT because 
they had already considered Down syndrome screening and wanted a more accurate 
assessment of risk. NIPT was essentially a continuation of this pathway. This was a finding 
that emerged during qualitative interviews. Future use of the Deliberation scale in this 
context could include rewording so that deliberation encompasses both screening and 
NIPT. A further reason may be because women do not give full consideration to NIPT 
because it is a blood test of which there are a number during pregnancy. This is a concern 
that has been raised previously by both patients and healthcare professionals.11,43 This 
emphasizes the importance of ensuring that as well as focussing on knowledge, health 
professionals must encourage patients to consider the implications of the test results,  
what information would be of benefit to them and what options might be available. We 
also found that women with a high risk screening result were more likely to deliberate on 
NIPT than those with an intermediate risk. This is not unexpected given that that those at 
a higher risk in this study may be weighing up the option of NIPT against invasive testing 
and may consider their decision in more depth because of the potential implications 
however, this finding does highlight the need for health professionals to ensure women 
with a DSS risk <1:150 give sufficient thought to the advantages and disadvantages of 
NIPT, particularly given that there is still a chance, albeit small, that the fetus may be 
affected.  
The methodology used to modify the MMIC has a number of notable strengths 
including the use of qualitative methods to explore the decision-making process, which 
has provided an additional dimension to the evaluation and validation of the modified 
MMIC.44 There was a high concordance between the modified MMIC and the interviews in 
determining whether an informed choice had been made. However, while overall the 
modified MMIC appears to be a robust measure of informed choice, like other measures it 
is not possible to pick up subtle nuances in decision-making that may be evident from 
qualitative interviews or clinical history.  For example, in one case there was a discordant 
result whereby the questionnaire indicated a non-deliberated decision. However, the 
interview revealed that the woman had in fact deliberated but that this had occurred much 
15 
 
earlier on in the process when considering DSS. For this woman, the decision to have NIPT 
was an extension of the decision to have screening and she therefore made the decision to 
accept NIPT relatively quickly and without much consideration. In another case a 
participant’s neutral attitude score was found to most likely stem from a dislike of needles 
rather than a neutral attitude to NIPT, which she viewed positively as an opportunity for 
reassurance. A further limitation of the MMIC is that it is unable to account for situations 
whereby a positive attitude towards NIPT is not behaviourally implemented for practical 
reasons e.g. being unwilling to return to the clinic for a blood test due to time or cost 
implications. These findings highlight a potential limitation of the questionnaire in that it is 
unable to capture the reasons underpinning women’s attitudes and highlights the value of 
a mixed methods approach supported by interviews as in this study.  
The measure was validated amongst women considering NIPT as a second 
screening test following a high or medium risk DSS result and not women using NIPT as a 
first screening test. Further validation would need to take place to use the measure among 
these different population groups. We were only able to recruit a small number of NIPT 
decliners (n=13) into the study and of these the vast majority were judged to have made 
an uniformed choice. However, given the small number, this finding should be interpreted 
with caution, particularly as others have reported higher rates of informed choice in 
screening decliners.19,27 Our sample predominantly comprised older, well educated 
women, however this probably reflects the fact that older women are more likely to be at 
increased risk and be highly educated as they have delayed child bearing for educational 
or vocational reasons. Currently, it is not clear whether NIPT will be offered as a 
contingent screening test or a first-line test offered to all women. Offering NIPT to a wider 
group of women may impact rates of informed choice and will thus require further 
assessment. Finally, the high rate of informed choice may reflect the fact that women 
were given up to 30 minutes pre-test counselling with a dedicated NIPT midwife and 
written information at a number of different points prior to decision-making. This degree 
of input may be challenging in routine clinical settings, especially if there is not the same 
16 
 
emphasis on pre-test counselling, highlighting the need for evaluation following 
implementation.    
 
CONCLUSION 
We have developed and validated a measure of informed choice for women offered NIPT 
for aneuploidy which can be used in other maternity settings. Previous concerns have 
been raised relating to routinisation of NIPT and erosion of informed choice given the 
relative ease with which NIPT can be conducted. Whilst recognizing that our sample 
comprised a high proportion of well educated women, our results indicate that given 
adequate information, time and expert pre-test counselling a high rate of informed choice 
can be achieved. Further research as and when NIPT is implemented into routine clinical 
settings is required.  
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Table 1: Participant Characteristics 
 
Participant Characteristics N=585 
Maternal age - mean,  (IQR) 35 years (32-39) 
Educational level  
  No qualification 1% (n=6) 
  GCSE or O level 8% (n=44) 
  GCE, A level or similar 8% (n=46) 
  Vocational (BTEC/NVQ/Diploma)  19% (n=111) 
  Degree level or above 64% (n=371) 
Ethnicity  
  White or White British  77% (n=438) 
  Asian or Asian British  11% (n=62) 
  Black or Black British 7% (n=39) 
  Other ethnic group  3% (n=17) 
  Mixed  3% (n=15) 
Religious faith  
  Yes 53% (n=302) 
  No 47% (n=271) 
Religion  
  Christian 75% (n=232) 
  Muslim  12% (n=38) 
  Jewish 5% (n=15) 
  Other 3% (n=8) 
  Sikh 2% (n=7) 
  Hindu 2% (n=7) 
  Buddhist 1% (n=3) 
Religiosity  
  Very  20% (n=50) 
21 
 
  Somewhat 66% (n=163) 
  Not at all 14% (n=34) 
DSS risk  
  Intermediate risk 72% (n=421) 
  High risk 28% (n=163) 
Further testing  
  NIPT 94% (n=548) 
  NIPT and invasive testing 4% (n=24)  
  No further testing 2% (n=13) 
NIPT on same day or different 
day as DSS 
 
  Different day 62% (n=357) 
  Same day 35% (n=200) 
  Same day but chose to return 4% (n=21) 
Parity  
  Parous  54% (n=306) 
  Nulliparous 47% (n=266) 
DSS in previous pregnancy      
  Yes 75% (n=240) 
  No 23% (n=73) 
  Not sure 3% (n=9) 
Have a child with Down’s 
syndrome 
 
  Yes <1% (n=1) 
  No 99.7% (n=329) 
Know a child with Down’s 
syndrome 
 
  Yes 29% (n=164) 
  No 71% (n=393) 
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Note: not all % add up to 100 due to rounding. Not all participants answered all questions 
and therefore there are some discrepancies with total numbers 
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Table 2: Summary of multidimensional measure of informed choice 
Measure Descriptio
n 
Items Reliabilit
y* 
Rang
e 
Cut-off Mea
n 
(S.D
) 
Outcome 
Knowledg
e scale 
Knowledge 
of NIPT, 
how it 
compares 
with 
standard 
DSS, 
options if 
the NIPT 
result is 
positive, 
knowledge 
about Down 
syndrome 
12 
question
s, 
multiple 
choice 
answers 
0.69 0-12 ≥9 = good 
knowledge 
11.1 
(1.5
) 
Good 
knowledg
e: 95% 
Attitude 
scale 
Attitude 
towards 
having NIPT 
Five 5-
point 
Likert 
items 
0.94 0-20 
0-6 = 
positive  
7-13 = 
neutral 
14-
20=negative 
2.2 
(3.7
) 
Positive: 
88% 
Negative: 
2% 
Neutral: 
10% 
Deliberati
on scale 
Evaluating 
alternatives
, 
considering 
consequenc
es, 
weighing up 
pros and 
cons 
Six 5-
point 
Likert 
items 
0.84 0-24 0-
12=deliberat
ed 
5.2 
(5.0
) 
Deliberate
d: 92% 
Uptake Whether 
NIPT was 
accepted or 
Choice 
of 4 
options: 
- - - - NIPT: 
94% 
NIPT and 
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declined NIPT, no 
further 
testing, 
straight 
for 
invasive
, 
invasive 
and 
NIPT  
invasive: 
4% 
No further 
testing: 
2% 
Informed 
choice** 
Good 
knowledge, 
deliberated, 
attitude and 
behaviour 
match. 
Calculat
ed 
- - - - 
 
Informed 
choice: 
89%  inc. 
deliberati
on  
94% excl. 
deliberati
on 
DSS: Down syndrome screening 
* Reliability was assessed using Cronbach’s alpha  
** Calculation does not include women with a neutral attitude 
 
